Toward the Definition of Patient-Reported Outcome Measurements in Hereditary Spastic Paraplegia-Reference-Cited by-同舟云学术

Toward the Definition of Patient-Reported Outcome Measurements in Hereditary Spastic Paraplegia

Published:2023-02 Issue:1 Volume:9 Page:
ISSN:2376-7839
Container-title:Neurology Genetics
language:en
Short-container-title:Neurol Genet

Author:

Amprosi Matthias¹^ORCID,Indelicato Elisabetta¹^ORCID,Eigentler Andreas¹,Fritz Josef¹,Nachbauer Wolfgang¹,Boesch Sylvia¹

Affiliation:

1. From the Centre for Rare Neurological Diseases (M.A., E.I., A.E., W.N., S.B.), Department of Neurology, Medical University of Innsbruck; and Department of Medical Statistics (J.F.), Informatics and Health Economics, Medical University of Innsbruck, Innsbruck, Austria.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Genetics (clinical),Neurology (clinical)

Link

https://www.neurology.org/doi/pdfdirect/10.1212/NXG.0000000000200052

Reference28 articles.

1. Hereditary spastic paraplegia: Clinicogenetic lessons from 608 patients

2. CLASSIFICATION OF THE HEREDITARY ATAXIAS AND PARAPLEGIAS

3. Overcoming the divide between ataxias and spastic paraplegias: Shared phenotypes, genes, and pathways

4. The Spastic Paraplegia Rating Scale (SPRS): A reliable and valid measure of disease severity

5. Scale for the assessment and rating of ataxia: Development of a new clinical scale

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Designing and validating a Hereditary Spastic Paraplegia-specific Quality of Life Rating Scale (HSPQoL);2024-07-24

2. Validation of the Italian version of a patient-reported outcome measure for Hereditary Spastic Paraplegia;PLOS ONE;2024-04-01

3. Development and validation of TreatHSP-QoL: a patient-reported outcome measure for health-related quality of life in hereditary spastic paraplegia;Orphanet Journal of Rare Diseases;2024-01-02

4. Long-term progression of clinician-reported and gait performance outcomes in hereditary spastic paraplegias;Frontiers in Neuroscience;2023-09-22

5. Outcome Measures and Biomarkers for Clinical Trials in Hereditary Spastic Paraplegia: A Scoping Review;Genes;2023-09-03